Journal
CELL
Volume 147, Issue 1, Pages 57-69Publisher
CELL PRESS
DOI: 10.1016/j.cell.2011.09.011
Keywords
-
Categories
Funding
- NIAMS NIH HHS [K08 AR055688-01A1S1, K08 AR055688-04, K08 AR055688-05, K08 AR055688] Funding Source: Medline
Ask authors/readers for more resources
Advances in genotyping and sequencing technologies have revolutionized the genetics of complex disease by locating rare and common variants that influence an individual's risk for diseases, such as diabetes, cancers, and psychiatric disorders. However, to capitalize on these data for prevention and therapies requires the identification of causal alleles and a mechanistic understanding for how these variants contribute to the disease. After discussing the strategies currently used to map variants for complex diseases, this Primer explores how variants may be prioritized for follow-up functional studies and the challenges and approaches for assessing the contributions of rare and common variants to disease phenotypes.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available